Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Jeong, Wonjeonga; b; 1 | Joo, Jae Honga; b | Kim, Hyunkyub; d | Kim, Yun Kyunga; b | Park, Eun-Cheolb; c | Jang, Sung-Inb; c; *
Affiliations: [a] Department of Public Health, Graduate School, Yonsei University, Seoul, Republic of Korea | [b] Institute of Health Services Research, Yonsei University, Seoul, Republic of Korea | [c] Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea | [d] Department of Psychiatry, Yonsei University College of Medicine, Seoul, Republic of Korea
Correspondence: [*] Correspondence to: Sung-In Jang, MD, PhD, Department of Preventive Medicine & Institute of Health Services Research, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul 03722, Republic of Korea. Tel.: +82 2 2228 1863; Fax: +82 2 392 8133; E-mail: jangsi@yuhs.ac.
Note: [1] Orcid: https://orcid.org/0000-0002-7334-0140
Abstract: Background:Hypnotics, including benzodiazepines, are extensively and inappropriately prescribed for older people to treat anxiety and sleep disorders, despite the adverse health outcomes associated with their use. Objective:This study aimed to examine the association of the use of long- and short-acting hypnotics with the risk of Alzheimer’s disease. Methods:Data from 234,634 participants, derived from the Korean National Health Insurance Service National Sample Cohort from 2002 to 2013, were examined. Individuals over the age of 50 years were included in the study. The dependent variable was the risk of Alzheimer’s disease. Hypnotics were categorized by the period of the prescription of benzodiazepines, i.e., either till the participants were diagnosed with Alzheimer’s disease or the end of the study period (December 31, 2013). Cox regression model was built to analyze the association between variables. Results:Individuals who used long-acting hypnotics were found to have a higher risk of Alzheimer’s disease than non-users. Moreover, among individuals with sleep disorders, those who used hypnotics had a higher risk of Alzheimer’s disease than those who did not. Conclusion:This study identified an association between the use of hypnotics and the risk of Alzheimer’s disease among South Korean middle-aged and older people.
Keywords: Alzheimer’s disease, benzodiazepines, dementia, hypnotics
DOI: 10.3233/JAD-201319
Journal: Journal of Alzheimer's Disease, vol. 81, no. 4, pp. 1381-1389, 2021
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl